✦ LIBER ✦

Combination of two anti-CD5 monoclonal antibodies synergistically induces complement-dependent cytotoxicity of chronic lymphocytic leukaemia cells

✍ Scribed by Klitgaard, Josephine L.; Koefoed, Klaus; Geisler, Christian; Gadeberg, Ole V.; Frank, David A.; Petersen, Jørgen; Jurlander, Jesper; Pedersen, Mikkel W.

Book ID: 121844799
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 444 KB
Category: Article
ISSN: 0007-1048
DOI: 10.1111/bjh.12503

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab anti-CD20 monoclonal antibody

Rituximab anti-CD20 monoclonal antibody induces marked but transient reductions of peripheral blood lymphocytes in chronic lymphocytic leukaemia patients

✍ M Ladetto; L Bergui; I Ricca; S Campana; A Pileri; C Tarella 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 744 KB

Reconstitution of the T-cell repertoire

Reconstitution of the T-cell repertoire following treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with B-cell chronic lymphocytic leukaemia

✍ Mohammad Reza Rezvany; Mahmood Jeddi Tehrani; Claes Karlsson; Jeanette Lundin; H 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB

Chronic lymphocytic leukaemia cells are

Chronic lymphocytic leukaemia cells are efficiently killed by an anti-CD20 monoclonal antibody selected for improved engagement of FcγRIIIA/CD16

✍ Christophe De Romeuf; Charles-Antoine Dutertre; Magali Le Garff-Tavernier; Natha 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB